Technology Press Releases
SEE OTHER BRANDS

Get your fresh news on technology in the world

Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

Press releases published on May 22, 2025

Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety. – NXC-201 demonstrated a complete response (CR) rate of 71% (5/7 patients) – …

Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants

Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants

ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced an …

Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results

Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results

Total revenues of US$18.2 million exceeds guidance, up 445.5% YoY Total ETH-based cryptocurrency units were approximately 7,023, up 23.2% QoQ Income from operations reach US$5.1 million, achieving turnaround from prior-year period SINGAPORE, May 22, 2025 ( …

Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China

Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China

Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002). Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for placebo; zero discontinuations due to …

TCT Expands Support for EU Financial Sector with Simpler DORA Compliance

TCT Expands Support for EU Financial Sector with Simpler DORA Compliance

TCT Portal supports compliance for virtually any regulation, including PCI DSS, GDPR, ISO standards, and now DORA ROCHESTER, MI, UNITED STATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- Total Compliance Tracking (TCT), a global leader in compliance software …

IPG Photonics Appoints Mira Sahney as Senior Vice President of Global Laser Systems

IPG Photonics Appoints Mira Sahney as Senior Vice President of Global Laser Systems

MARLBOROUGH, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP), the global leader in high-performance fiber lasers and laser systems, announced the appointment of Mira Sahney as Senior Vice President, Global Laser Systems. …

 Skywork.ai Launches Globally, Introducing the World’s First DeepResearch-Powered Workspace Super Agents

Skywork.ai Launches Globally, Introducing the World’s First DeepResearch-Powered Workspace Super Agents

Singapore , May 22, 2025 (GLOBE NEWSWIRE) -- In May 2025, Skywork.ai officially entered the global stage, launching the world’s first AI Office Suite powered by DeepResearch technology, with full support for both English and Japanese to enhance …

Innopay Appoints Nagendra Vinukollu as Head of Product to Drive 10X Growth and Innovation

Innopay Appoints Nagendra Vinukollu as Head of Product to Drive 10X Growth and Innovation

BENGALURU, KARNATAKA, INDIA, May 22, 2025 /⁨EINPresswire.com⁩/ -- Innopay Technologies, an emerging leader in BBPS payments, announced the appointment of Nagendra Vinukollu as Head of Product Management, strengthening the company's vision to innovate in …

Unily and Microsoft Unveil Co-Developed Microsoft 365 Graph Connector and Copilot at Microsoft Build

Unily and Microsoft Unveil Co-Developed Microsoft 365 Graph Connector and Copilot at Microsoft Build

Unily and Microsoft launch a native M365 Connector and Copilot, turning intranet content into secure, searchable, and actionable insights. NEW YORK, NY, UNITED STATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- Unily, the leading Employee Experience Platform ( …

ESG AI Launches ESG Risk Platform to Power Banks & Insurers with Instant ESG Risk Visibility on Any Business, Anywhere

ESG AI Launches ESG Risk Platform to Power Banks & Insurers with Instant ESG Risk Visibility on Any Business, Anywhere

ESG AI launches global platform enabling banks, insurers …

SOAX Acquires ProxyWow to Strengthen Infrastructure and Accelerate Access to Reliable Web Data at Scale

SOAX Acquires ProxyWow to Strengthen Infrastructure and Accelerate Access to Reliable Web Data at Scale

Strategic acquisition boosts SOAX’s infrastructure …

floLIVE Receives Frost & Sullivan 2025 Enabling Technology Leadership Award

floLIVE Receives Frost & Sullivan 2025 Enabling Technology Leadership Award

Wireless connectivity provider is recognized for “leveraging vital technology to enhance products and applications.” LONDON, UNITED KINGDOM, May 22, 2025 /⁨EINPresswire.com⁩/ -- floLIVE, a global enabler of IoT connectivity solutions, announced it has …

Recode Ventures' Vishal Gulati Elected Fellow Of Academy Of Medical Sciences For Contributions To Translational Medicine

Recode Ventures' Vishal Gulati Elected Fellow Of Academy Of Medical Sciences For Contributions To Translational Medicine

Healthcare Venture Capitalist Vishal Gulati Inducted Into The Academy Of Medical Sciences In Recognition Of His Role In Translational Medicine. LONDON, UK, UNITED KINGDOM, May 22, 2025 /⁨EINPresswire.com⁩/ -- Recode Ventures is honoured to announce that …

Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease

Endurance Bio Inc. Announces Selection of T-168 for Neuro-SysMed’s SLEIPNIR Platform Trial in Parkinson’s Disease

SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Endurance Bio Inc., a clinical-stage biotechnology company developing therapies for neurodegenerative and metabolic diseases, today announced that its compound, T-168, has been selected for testing on …

Big Data, Data Lake & Analytics Companies and Services Now One Click Away with SQL Plus one Specialized Listing Platform

Big Data, Data Lake & Analytics Companies and Services Now One Click Away with SQL Plus one Specialized Listing Platform

New platform launches to connect businesses with top Big Data …

CSGO Betting Sites: Thunderpick Named the Top U.S. Sportsbook for Counter-Strike: Global Offensive

CSGO Betting Sites: Thunderpick Named the Top U.S. Sportsbook for Counter-Strike: Global Offensive

New York City, May 22, 2025 (GLOBE NEWSWIRE) -- Thunderpick has redefined the CSGO betting experience for players across the U.S., offering everything a serious bettor could want in one streamlined platform. With competitive odds, real-time match coverage, …

Best Sportsbook Promos: SportsBetting.ag Picked as the Top US Site for Sports Betting Bonuses

Best Sportsbook Promos: SportsBetting.ag Picked as the Top US Site for Sports Betting Bonuses

Belize City, May 22, 2025 (GLOBE NEWSWIRE) -- When it comes to finding the best sportsbook promos site for US players, SportsBetting.ag stands out for one simple reason: it offers more value, more often. From generous sign-up bonuses to ongoing reloads and …

Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older

Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older

Once-daily ZORYVE foam provides powerful clearance and rapid itch relief from head to toe with no limitation on duration of use More than half of the nearly 9 million people in the United States with plaque psoriasis experience scalp involvement Healthcare …

The Vallourec General Shareholders' Meeting of 22 May 2025 Voted in Favor of All the Resolutions and Approved the First Dividend in a Decade

The Vallourec General Shareholders' Meeting of 22 May 2025 Voted in Favor of All the Resolutions and Approved the First Dividend in a Decade

Press release THE VALLOUREC GENERAL SHAREHOLDERS' MEETING OF 22 MAY 2025 VOTED IN FAVOR OF ALL THE RESOLUTIONS AND APPROVED THE FIRST DIVIDEND IN A DECADE Meudon (France), May 22, 2025 – Vallourec, a world leader in premium seamless tubular solutions, …

L’ASSEMBLEE GENERALE DE VALLOUREC DU 22 MAI 2025  ADOPTE L’ENSEMBLE DES RESOLUTIONS SOUMISES AU VOTE  ET APPROUVE LE PREMIER DIVIDENDE DEPUIS 10 ANS

L’ASSEMBLEE GENERALE DE VALLOUREC DU 22 MAI 2025 ADOPTE L’ENSEMBLE DES RESOLUTIONS SOUMISES AU VOTE ET APPROUVE LE PREMIER DIVIDENDE DEPUIS 10 ANS

Communiqué de presse L’ASSEMBLEE GENERALE DE VALLOUREC DU 22 MAI 2025 ADOPTE L’ENSEMBLE DES RESOLUTIONS SOUMISES AU VOTE ET APPROUVE LE PREMIER DIVIDENDE DEPUIS 10 ANS Meudon (France), le 22 mai 2025 – Vallourec, un leader mondial des solutions tubulaires …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service